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This data article contains information on glutathione sulfonamide
(GSA) structural confirmation and purity after synthesis, as well as
mass spectrometry acquisition parameters for the determination of
GSA and other biomarkers for the early assessment of intraamniotic
fluid infection in amniotic fluid samples (Cháfer-Pericás et al., 2015)
[1]. GSA standards were synthesized and structural confirmation was
carried out employing time-of-flight mass spectrometry (TOF-MS);
purity was assessed by high performance liquid chromatography
(HPLC) with UV detection. For optimization of the acquisition para-
meters of GSA and other biomarkers, individual analytical standard
solution at a concentration of 1 mmol L1 was injected into an
Acquity – Xevo TQ liquid-chromatography coupled to tandem mass
spectrometry (LC-MS/MS) system from Waters (Milford, MA, USA)
operating in the positive electrospray (ESIþ) mode. Mass spectro-
metric detection of 3-nitro-tyrosine (3NO2-Tyr), 3-chloro-tyrosinevier Inc. This is an open access article under the CC BY license
/j.freeradbiomed.2015.09.014
Unit, Health Research Institute La Fe, Valencia, Avenida Fernando Abril
1245688.









C. Cháfer-Pericás et al. / Data in Brief 5 (2015) 1026–1030 1027(3Cl-Tyr), 8-hydroxy-2′-deoxyguanosine (8OHdG), GSA and oxidized
glutathione (GSSG) was carried out by multiple reaction monitoring
(MRM). Linear response curves were calculated for each analyte
normalizing the signal with peak areas of internal standards.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Specifications Tableubject area Medicine
ore specific sub-
ject areaObstetrics & Gynecologyype of data Figures & table
ow data was
acquiredTOF-MS, HPLC-UV, LC-ESI(þ)-MS/MSata format Structural confirmation/purity & LC-MS/MS acquisition parameters
xperimental
factorsNone appliedxperimental
featuresTOF-MS for structural elucidation and HPLC-UV for purity assessment of syn-
thetized GSA; LC-ESI(þ)-MS/MS acquisition parameters for each biomarkerata source
locationValencia, Spainata accessibility Data are with this articleD1. Value of the data GSA standard was synthetized and its molecular structure was confirmed by TOF-MS.
 Purity of the GSA standard was assessed employing HPLC-UV.
 LC-MS/MS for the simultaneous quantification of potential biomarkers in small sample volumes.
 MRM acquisition enabling a highly specific and sensitive analytical response.
 Linear response curves for each biomarker normalized by peak area values obtained from internal
standard solutions for improved reproducibility.2. Data, materials and methods
2.1. GSA standards
GSA was synthesized and purified as described by Harwood et al. [2] by treating an aqueous GSH
solution with hypochlorite solution in phosphate buffer (pH 7.4) at an equimolar ratio
(100 mmol L1) at room temperature. GSA was purified by manual collection of fractions from a
Shimadzu Scientific Instruments (Columbia, MD, USA) high performance liquid chromatographic
(HPLC) system equipped with a Halo C18 column (2.1100 mm, 2.7 mm) from Advanced Materials
Technology (Wilmington, DE, USA) and using an injection volume of 50 mL. Chromatograms were
acquired using UV detection at 222 and 254 nm. Separation was achieved using an H2O (0.1% formic
acid): methanol gradient and a flow rate of 0.5 mL min1; gradient conditions were set as follows:
from 0 to 3 min 2% methanol; from 3 to 6 min from 2% to 98% methanol; from 6 to 10 min 98%
methanol; from 10 to 10.1 min from 98% to 2% methanol and from 10.1 to 14 min 2% methanol. The
collected fractions were lyophilized to obtain a fluffy white powder which at 20 °C was stable over a





















Fig. 1. TOF-MS spectrum of GSA fraction. Note: Molecular formula of GSA: C10H15N3O8S, theoretical molecular weight of GSA:
337.05744.
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Fig. 2. Chromatograms from a GSA containing fraction (triplicate injection) after purification and a blank injection.
C. Cháfer-Pericás et al. / Data in Brief 5 (2015) 1026–10301028period of several months. In the obtained fractions, the presence of GSA was confirmed by recording
full scan direct infusion TOF-MS spectra employing an ABSciex 5600-Triple TOF-MS spectrometer
(Framingham, MA, USA) operating in the ESIþ mode. Fig. 1 shows a TOF-MS spectrum of a GSA
containing fraction in the region between 250 and 400 m/z. Four peaks with intensities 4500 counts
were identified and three of them could be assigned to the molecular ion of GSA and GSA adducts,
respectively. The purity of the obtained GSA was determined from three independent runs to be
9172% employing the above-described HPLC-UV method and measuring the GSA peak area vs. the
total area under the curve in chromatograms recorded at 254 nm. Fig. 2 shows chromatograms of a
GSA containing fraction and a blank injection.
2.2. LC-MS/MS acquisition parameters for biomarker determination in AF samples
An Acquity – Xevo TQ from Waters (Milford, MA, USA) operating in the ESIþ mode was used for
the analysis of standard solutions and processed amniotic fluid samples (details can be found in [1]).
Parameters were set as follows: capillary voltage was 3.2 kV, source temperature was 150 °C,
Table 1
LC-ESI(þ)-MS/MS acquisition parameters.
Analyte m/z parent ion Cone [V] m/z daughter ion CE [eV]
3NO2-Tyr 227.1 25 181 10
3Cl-Tyr 216 30 170 15
8OHdG 284 30 168 15
GSA 338 45 155.1 25
GSSG 613.2 50 355 35
8OHdG-C13N15 284 30 168 15
Phe-D5 171.5 30 125 20
Meth-D3 153 30 63.5 25
CE: collision energy; 3NO2-Tyr: 3-nitro-tyrosine; 3Cl-Tyr: 3-chloro-tyrosine; 8OHdG: 8-hydroxy-2' -deoxyguanosine; GSA:
glutathione sulfonamide; GSSG: oxidized glutathione; 8OHdG-C13N15: 8-hydroxy-2'-deoxyguanosine-C13,N15; Phe-D5:
phenylalanine-D5, Meth-D3: methionine-D3.
C. Cháfer-Pericás et al. / Data in Brief 5 (2015) 1026–1030 1029desolvation temperature was 395 °C, nitrogen cone and desolvation gas flows were 150 and
800 L h1, respectively and the dwell time was 5 ms. For MS parameter optimization, individual
standard solutions of each biomarker at a concentration of 1 mmol L1 were injected. For LC
separations, a Kinetex C8 column (1002.1 mm, 1.7 mm) from Phenomenex was used running a
gradient employing H2O (0.1% v/v formic acid) and acetonitrile (0.1% v/v formic acid) as mobile phases
A and B with gradient conditions as follows: from 0 to 1.25 min 1% B; from 1.25 to 4.75 min the
mobile phase composition changed from 1% to 98% B; from 4.75 to 5 min 98% B; from 5 to 5.1 min the
gradient returned to its initial conditions of 1% B which were held until 6 min. Flow rate, column
temperature and injection volume were set to 0.4 mL min1, 45 °C and 2 mL, respectively. Samples
were kept in the autosampler at 4 °C during batch analysis. Multiple reaction monitoring (MRM) was
carried out employing the acquisition parameters summarized in Table 1. MassLynx 4.1 and QuanLynx
4.1 fromWaters (Milford, MA, USA) were used for data acquisition and processing, respectively. Linear
response curves were calculated for each biomarker normalizing with peak areas of internal
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